Quantbot Technologies’s Altimmune ALT Stock Holding History

Quantbot Technologies’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$139K	Buy	+45,632	New	+$136K	0.01%	1380
2025 Q1	–	Sell	-60	Closed	-$433	–	1443
2024 Q4	$433	Buy	+60	New	+$458	﹤0.01%	1413
2023 Q4	–	Sell	-15,300	Closed	-$39.8K	–	1543
2023 Q3	$39.8K	Buy	+15,300	New	+$43.9K	﹤0.01%	1282
2023 Q2	–	Sell	-2,077	Closed	-$8.77K	–	1539
2023 Q1	$8.77K	Sell	2,077 -11,518	-85%	-$137K	﹤0.01%	1418
2022 Q4	$224K	Sell	13,595 -8,943	-40%	-$100K	0.02%	858
2022 Q3	$287K	Buy	+22,538	New	+$333K	0.02%	768

Other funds holding ALT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantbot Technologies's ALT Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Altimmune (ALT) in Q2 2026: 45,632 shares worth $139K. The stake represents 0.01% of the portfolio and ranks #1380 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in ALT as recently as Q4 2024.

Quantbot Technologies first reported a position in ALT in Q3 2022 and has held it in 6 quarters since. The position peaked at $287K in Q3 2022. 211 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

Quantbot Technologies held 45,632 shares of Altimmune worth $139K as of Q2 2026.
Altimmune was a new Quantbot Technologies position in Q2 2026.
Altimmune made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1380 holding.
Quantbot Technologies first reported a position in Altimmune in Q3 2022 and has held it in 6 quarters since.
Quantbot Technologies's Altimmune position peaked at $287K in Q3 2022.
211 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.